SCHEMBL6175510

SCHEMBL6175510

CC1(Cc2ccncc2-c2ccc(Cl)cc2)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 15/20 0.45
AR P10275 2/20 0.37
SLC22A12 Q96S37 1/20 0.37
ITGAL P20701 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173726 0.90 IGF1R (0.42) IGF1RARITGAL
SCHEMBL6173060 0.90 IGF1R (0.42) IGF1RARSLC22A12
SCHEMBL6173951 0.87 IGF1R (0.44) IGF1RARITGAL
SCHEMBL6172098 0.86 AR (0.37) ARITGAL
SCHEMBL6171779 0.85 IGF1R (0.40) IGF1RARSLC22A12ITGAL
SCHEMBL6173545 0.84 IGF1R (0.46) IGF1RAR
SCHEMBL6174069 0.84 IGF1R (0.48) IGF1RAR
SCHEMBL6174374 0.84 IGF1R (0.48) IGF1RAR
SCHEMBL6175503 0.84 IGF1R (0.48) IGF1RAR
SCHEMBL6173621 0.83 IGF1R (0.42) IGF1RAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed